82832.HK Bosera STAR 50 ETF down 5.78% on 24 Mar 2026: watch HKD 8.30–9.23 range

A sharp volume spike drove 82832.HK stock lower on 24 Mar 2026, with the Bosera STAR 50 Index ETF (82832.HK) closing at HKD 7.99, down 5.78% on turnover of 54,600 shares versus an average of 963. The gap between the 50-day average HKD 9.23 and the 200-day average HKD 8.30 frames the immediate technical context. We examine the trade drivers, technical signals, and model forecasts, and show what traders should watch next given the ETF’s exposure to the SSE Science and Technology Innovation Board 50 Index on the HKSE.

Volume spike and price action

Trading volume of 54,600 versus average 963 produced a relVolume of 56.70, a clear volume spike that preceded the HKD 0.49 intraday fall to HKD 7.99. This single-day surge in activity suggests distribution at higher levels after the ETF opened at HKD 8.745 and hit a day high of HKD 8.76.

Technical signals for 82832.HK stock

Momentum indicators show weakness: RSI 37.09, MACD histogram -0.10, and CCI -107.80 indicate oversold or bearish momentum. The ETF sits below the 50-day average HKD 9.2334 and near the 200-day HKD 8.30099, making HKD 8.30 a nearer-term technical pivot.

Fundamentals and valuation snapshot

As an ETF, Bosera STAR 50 Index ETF tracks the SSE STAR 50 Index and has limited standalone earnings metrics. Reported EPS is 0.19 and a reported PE of 41.80 reflects index-driven valuation rather than fund operations. Market cap data shows 8,028,991 (from the feed) and shares outstanding 1,004,880, but key ETF metrics such as dividend yield are not applicable.

Meyka AI grade and model forecasts

Meyka AI rates 82832.HK with a score out of 100: 59.61, Grade C+, Suggestion HOLD. This grade factors S&P 500 and sector comparisons, financial growth, key metrics, forecasts, analyst consensus, and fundamental growth.

Trading setup, price targets and risk

Short-term traders should watch resistance at the 50-day mean HKD 9.23 and support near the 200-day mean HKD 8.30 and the year low HKD 5.75. We set a tactical price target range: conservative HKD 9.50, base HKD 11.48 (Meyka yearly forecast), and optimistic HKD 16.64 over three years. Stop-loss placement below HKD 7.50 limits downside given the volume spike and volatile STAR-board exposure.

Sector context and resources

The ETF sits in Financial Services and Asset Management with heavy exposure to China’s technology and STAR board stocks. Technology sector weakness in Hong Kong has pressured high-beta innovation names, which amplifies ETF swings. For official listings and index methodology, see HKEX ETF listings and the SSE STAR 50 index overview on the Shanghai exchange SSE English site. For portfolio details on this ticker, see the Meyka stock page Meyka: 82832.HK.

Final Thoughts

The volume spike on 24 Mar 2026 marks a clear liquidity event for 82832.HK stock and signals a tactical reassessment for holders and traders. At HKD 7.99, the ETF sits below both the 50-day average HKD 9.23 and just under the 200-day average HKD 8.30, leaving the immediate technical picture biased toward risk. Meyka AI’s forecast model projects HKD 11.48 for the next year, implying an upside of 43.63% versus the current price, and a monthly model figure of HKD 8.89 (implied upside 11.26%). These projections are model-based and not guarantees. Given the ETF’s high relative volume (relVolume 56.70) and negative momentum indicators (RSI 37.09, MACD hist -0.10), short-term traders may prefer defined risk strategies around HKD 8.30–9.23 and use stop-losses to manage volatility. Longer-term investors who seek STAR board exposure should weigh sector concentration, elevated PE dynamics, and model forecasts against portfolio objectives. Meyka AI provides this AI-powered market analysis to inform decisions; it is not financial advice.

FAQs

Disclaimer:

Stock markets involve risks. This content is for informational purposes only. Past performance does not guarantee future results. Meyka AI PTY LTD provides market analysis and data insights, not financial advice. Always conduct your own research and consider consulting a licensed financial advisor.